InvestorsHub Logo
Followers 57
Posts 5697
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Tuesday, 09/12/2017 6:16:34 PM

Tuesday, September 12, 2017 6:16:34 PM

Post# of 6035
The phase II NSCLC trial must be going well...certainly that is the basis of the Type C meeting with the FDA. They now are in 8 centres and are "expanding rapidly over the next few months." It was also important to hear that while current courses of treatment could cost $35,000 to $50,000, ImPACT COGS would be "...well under $1,000".

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NHWK News